Jaguar Animal Health Nachrichten und Aktivitäten
Präsenz
Jaguar Animal Health ist ein Unternehmen, das unter dem Börsenticker JAGX (US) gelistet ist.
Jaguar Animal Health hat eine direkte Präsenz in 2 Ländern.
Sie befinden sich in:
- Gesundheitswesen67%
- Pharmazie33%
Führungskräfte
Siehe das Organigramm mit seine 26 wichtigsten Führungskräfte
Die meist gesuchten Biographien bei Jaguar Animal Health
- Lisa Conte, Chief Executive Officer, Executive Director
- John Micek, Director
- James Bochnowski, Chairman of the Board
Eine Benachrichtigung erstellen
um Veränderungen bei Führungskräften von Jaguar Animal Health nachzuverfolgen.
Pharmazie
Jaguar Animal Health hat 1.824 Konkurrenten , einschließlich Pfizer (USA), Sanofi (Frankreich) und Roche (Schweiz).
Popular M&A news in Pharmazie
- Cyclo Therapeutics hat Rafael Holdings erworben (veröffentlicht am 28, April 2025).
- Chimerix and Chimerix have merged (veröffentlicht am 22, April 2025)..
- Imbria Pharmaceuticals hat gerade eine Spendenaktion von 58 Millionen Dollar angekündigt. (veröffentlicht am 10, April 2025).
Andere vorgeschlagene Kontakte der Pharmazie branche
Nachrichten
Neueste Pressemitteilungen nach Jaguar Animal Health
- Jaguar Health Appoints Senior Healthcare and Investment Executive Dr. Anula Jayasuriya to Board of Directors and Forms Business Development Advisory Committee to Assess Opportunities for Alliances, Mergers, and Acquisitions | Jaguar Health, Inc.
- Jaguar Health Enters Exclusive Crofelemer License and Commercialization Agreement with SynWorld Technologies for Canalevia for Treatment of Diarrhea in Dogs in China | Jaguar Health, Inc.
- Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Jaguar Health, Inc.
- Jaguar Health Announces Online Availability of a Presentation on Short Bowel Syndrome (SBS) by Dr. Mohamad Miqdady at Elite Ped-GI Congress in Abu Dhabi | Jaguar Health, Inc.
- Jaguar Animal Health Exhibiting at the June 23-25 American College of Veterinary Internal Medicine (ACVIM) Forum as Part of Ongoing Commercial Launch Activities for Canalevia-CA1 | Jaguar Health, Inc.
- Jaguar Health Announces Publication of Onco'Zine Article Underscoring the Importance of Controlling Diarrhea in Cancer Patients | Jaguar Health, Inc.
- Jaguar Health Reports Voting Results from 2022 Annual Meeting of Stockholders | Jaguar Health, Inc.
- Jaguar Health to Participate in BIO International Convention (BIO 2022) | Jaguar Health, Inc.
- Jaguar Health and Filament Health Sign Letter of Intent to Develop Botanical Prescription Drugs for Specific Mental Health Indications | Jaguar Health, Inc.
- Jaguar Health Announces Napo Therapeutics' Submission of Orphan Drug Designation Application to the European Medicines Agency for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Condition | Jaguar Health, Inc.
- View more press releases Close
Social media about Jaguar Animal Health
- Jaguar Animal Health auf Wikipedia, Google News & Yahoo Finance
- Jaguar Animal Health auf LinkedIn, Twitter & YouTube
